Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

2016/06/11 by Andrea Cipriani, Xinyu Zhou, Cinzia Del Giovane +20 · 3 citations
Decision Sciences · Medicine · Psychology · #Attention Deficit Hyperactivity Disorder #Child and Adolescent Psychosocial and Emotional Development #Meta-analysis and systematic reviews

paper · doi:10.1016/s0140-6736(16)30385-3

openalex publication_date 2016/06/11 · crossref created 2016/06/11 · crossref issued 2016/08/01 · crossref published 2016/08/01 · crossref published-print 2016/08/01 · crossref deposited 2024/06/17 · openalex created_date 2025/10/10 · crossref indexed 2026/07/27 · openalex updated_date 2026/08/04

Citations

• Human resources for mental health care: current situation and strategies for action
• General Methods for Monitoring Convergence of Iterative Simulations
• Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
• Evaluation of networks of randomized trials
• Statistical power analysis for the behavioral sciences
• A RATING SCALE FOR DEPRESSION
• Newer generation antidepressants for depressive disorders in children and adolescents
• Checking consistency in mixed treatment comparison meta‐analysis
• Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
• Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression

Cited by

• Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects
• Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management
• Antidepressant [wikipedia]